Literature DB >> 23105611

Association of plasma level of thiobarbituric acid reactive substances with extent of hepatocellular injury in preterm infants with cholestatic jaundice.

Rinchen D Bhutia1, Bhumika Upadhyay, M Maneesh.   

Abstract

The present study was designed to determine the association between extent of hepatocellular injury and plasma level of thiobarbituric acid reactive substances (TBARS) in pre term infants with cholestasis. Preterm infants (<35 weeks gestation) admitted to the neonatal intensive care unit were enrolled (with their parents informed consent) in either the 'cholestasis' group (if their direct bilirubin was >2 mg/dl) (n=25) or in the control group (n=16). Blood samples for measurement of TBARS, direct bilirubin and transaminases were obtained with-in 24 hours of enrollment. The cholestasis and control groups were comparable with respect to gestational age, birth weight and Apgar score. Serum direct bilirubin, SGOT (EC 2.6.1.1) and SGPT (EC 2.6.1.2) levels were significantly high in the cholestasis group. Plasma levels of TBARS in cholestasis group were correlated with SGOT (F=276.92; P<0.0001) and SGPT (F=355.17; P<0.0001) and differed significantly between cholestatic and control infants. Our findings suggest that oxidative stress in preterm infants with cholestasis is associated with hepatocellular injury.

Entities:  

Keywords:  Bilirubin; Cholestasis; Infants; TBARS; Transaminase

Year:  2006        PMID: 23105611      PMCID: PMC3454002          DOI: 10.1007/BF02912909

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  8 in total

Review 1.  Mechanisms of hepatotoxicity.

Authors:  Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

2.  Bile duct ligation and oxidative stress in the rat: effects in liver and kidney.

Authors:  M Orellana; R Rodrigo; L Thielemann; V Guajardo
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2000-06       Impact factor: 3.228

3.  Reactive oxygen intermediates and eicosanoid production by kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4.

Authors:  L Alric; C Orfila; N Carrere; M Beraud; G Carrera; J C Lepert; M Duffaut; B Pipy; J P Vinel
Journal:  Inflamm Res       Date:  2000-12       Impact factor: 4.575

4.  Does total antioxidant status relate to outcome in very preterm infants?

Authors:  J A Drury; J A Nycyk; M Baines; R W Cooke
Journal:  Clin Sci (Lond)       Date:  1998-02       Impact factor: 6.124

5.  Catalase, superoxide dismutase and glutathione peroxidase activities of lung and liver during human development.

Authors:  M C McElroy; A D Postle; F J Kelly
Journal:  Biochim Biophys Acta       Date:  1992-09-15

Review 6.  Free radical-lipid interactions and their pathological consequences.

Authors:  C Rice-Evans; R Burdon
Journal:  Prog Lipid Res       Date:  1993       Impact factor: 16.195

7.  Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis.

Authors:  R J Sokol; D Twedt; J M McKim; M W Devereaux; F M Karrer; I Kam; G von Steigman; M R Narkewicz; B R Bacon; R S Britton
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

8.  Association of lipid peroxidation with hepatocellular injury in preterm infants.

Authors:  Barry Weinberger; Kazimierz Watorek; Richard Strauss; Gisela Witz; Mark Hiatt; Thomas Hegyi
Journal:  Crit Care       Date:  2002-08-21       Impact factor: 9.097

  8 in total
  1 in total

Review 1.  A Summary of New Findings on the Biological Effects of Selenium in Selected Animal Species-A Critical Review.

Authors:  Bozena Hosnedlova; Marta Kepinska; Sylvie Skalickova; Carlos Fernandez; Branislav Ruttkay-Nedecky; Thembinkosi Donald Malevu; Jiri Sochor; Mojmir Baron; Magdalena Melcova; Jarmila Zidkova; Rene Kizek
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.